Floersheim GL. 1994. Allopurinol, indomethacin and riboflavin enhance radiation lethality in mice. Pediatrics 139:240–247.


Levy G, Jusko WJ. 1966. Factors affecting the absorption of riboflavin in man. J Pharm Sci 55:285–289.


McCormick DB. 1977. Interactions of flavins with amino acid residues: Assessments from spectral and photochemical studies. Photochem Photobiol 26:169–182.

McCormick DB. 1997. Riboflavin. In: Shils ME, Olson JE, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease. Baltimore, MD: Williams and Wilkins.


Schoenen J, Lenaerts M, Bastings E. 1994. Rapid communication: High-dose riboflavin as a prophylactic treatment of migraine: Results of an open pilot study. Cephalalgia 14:328–329.

Spector A, Wang GM, Wang RR, Li WC, Kleiman NJ. 1995. A brief photochemically induced oxidative insult causes irreversible lens damage and cataracts. 2. Mechanism of action. Exp Eye Res 60:483–493.

Stripp B. 1965. Intestinal absorption of riboflavin by man. Acta Pharmacol Toxicol 22:353–362.

Sugiyama M, Tsuzuki K, Lin X, Costa M. 1992. Potentiation of sodium chromate (VI)-induced chromosomal aberrations and mutation by vitamin B2 in Chinese hamster V79 cells. Mutat Res 283:211–214.


Zempleni J, Galloway JR, McCormick DB. 1996. Pharmacokinetics of orally and intravenously administered riboflavin in healthy humans. Am J Clin Nutr 63:54–66.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement